Vaccines for typhoid prevention, including inactivated, Vi polysaccharide, and conjugate formulations; supplied to public health programs, hospitals, clinics, and contract manufacturers. Key buyers include government health agencies, NGOs, and international procurement bodies; distributed through pharmaceutical distributors and wholesaler networks.